SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001826466-24-000128
Filing Date
2024-10-01
Accepted
2024-10-01 15:39:28
Documents
13
Period of Report
2024-09-23
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 11732
  Complete submission text file 0001826466-24-000128.txt   174611

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nkph-20240923.xsd EX-101.SCH 3048
3 XBRL LABEL FILE nkph-20240923_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE nkph-20240923_pre.xml EX-101.PRE 22381
16 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3121
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

IRS No.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56234 | Film No.: 241342975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)